Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I7CE
|
||||
Former ID |
DNC012449
|
||||
Drug Name |
SK&F-89626
|
||||
Synonyms |
SK-89626
|
||||
Indication | Discovery agent | Investigative | [530341] | ||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1C(C2=C(CN1)SC=C2)C3=CC(=C(C=C3)O)O
|
||||
InChI |
1S/C13H13NO2S/c15-11-2-1-8(5-12(11)16)10-6-14-7-13-9(10)3-4-17-13/h1-5,10,14-16H,6-7H2
|
||||
InChIKey |
QDKUSZZMIFQVPN-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [530341] | |
Dopamine D1 receptor | Target Info | Inhibitor | [530341] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Dopamine receptor mediated signaling pathway | |||||
Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.